Insight Molecular Diagnostics Inc.
IMDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001642380
No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.
Holders of 5% or more of IMDX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Insight Molecular Diagnostics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Broadwood Partners, L.P. | 13D/A | 39.70%12.8M shares | +2.30 ppfrom 37.40% | Feb 10, 20253 filings | Apr 27, 2026 | SEC |
| Smith Patrick W | 13G/A | 10.50%1.77M shares | – | Dec 27, 20241 filing | Dec 27, 2024 | SEC |
| AWM Investment Company, Inc. | 13G/A | 10.00%2.86M shares | +2.50 ppfrom 7.50% | Feb 14, 20252 filings | May 9, 2025 | SEC |
| Bio-Rad Laboratories, Inc. | 13G/A | 9.70%2.76M shares | – | Mar 4, 20251 filing | Mar 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on Insight Molecular Diagnostics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 27, 20267:14 PM ET | Broadwood Partners, L.P.and 2 others | 13D/A | 39.70%12.8M shares | +2.30 ppfrom 37.40% | Apr 23, 2026 | SEC |
| Feb 12, 20267:52 PM ET | Broadwood Partners, L.P.and 2 others | 13D/A | 37.40%12.1M shares | −2.80 ppfrom 40.20% | Feb 10, 2026 | SEC |
| May 9, 20254:06 PM ET | AWM Investment Company, Inc. | 13G/A | 10.00%2.86M shares | +2.50 ppfrom 7.50% | Mar 31, 2025 | SEC |
| Mar 4, 20257:06 PM ET | Bio-Rad Laboratories, Inc. | 13G/A | 9.70%2.76M shares | – | Feb 10, 2025 | SEC |
| Feb 14, 20252:41 PM ET | AWM Investment Company, Inc. | 13G/A | 7.50%1.31M shares | – | Dec 31, 2024 | SEC |
| Feb 10, 20258:46 PM ET | Broadwood Partners, L.P.and 2 others | 13D/A | 40.20%11.6M shares | – | Feb 6, 2025 | SEC |
| Dec 27, 20249:58 PM ET | Smith Patrick Wand 1 other | 13G/A | 10.50%1.77M shares | – | Dec 26, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Insight Molecular Diagnostics Inc. shares.
No Form 144 notices for Insight Molecular Diagnostics Inc. are on file.